Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
Clinical trial NCT06020014 · COMPLETED
Trial details
- NCT number
- NCT06020014
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2025-10-28
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.